Oncologix Tech, Inc.
OCLGOTCFinancial Services● Active
$0.00
+$0.00(+0.00%)
Market Cap$73662
P/E Ratio—
52W High$0.001
52W Low$0.0001
Oncologix Tech, Inc. (OCLG) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · OCLG · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2017-08 | 2016-08 | 2015-08 | 2014-08 | 2013-08 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.85M | $4.01M | $4.90M | $3.68M | $0.24M |
| Cost of Revenue | $2.28M | $2.80M | $3.53M | $3.06M | $0.20M |
| Gross Profit | $0.57M | $1.22M | $1.37M | $0.61M | $0.05M |
| Gross Margin %(computed) | 20.05% | 30.28% | 28.01% | 16.71% | 19.88% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.03M | $0.00M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $1.13M | $0.33M |
| Total Operating Expenses | $1.44M | $1.73M | $1.88M | $1.19M | $0.33M |
| Operating Income | ($0.86M) | ($0.51M) | ($0.51M) | ($0.57M) | ($0.29M) |
| Operating Margin %(computed) | -30.35% | -12.76% | -10.38% | -15.56% | -117.50% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $1.25M | $0.70M | $1.61M | $0.81M | $0.19M |
| Income Before Tax | ($2.37M) | ($1.85M) | ($2.55M) | ($1.41M) | ($0.65M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($2.37M) | ($1.85M) | ($2.55M) | ($1.31M) | ($0.65M) |
| Net Margin %(computed) | -83.19% | -46.09% | -52.08% | -35.68% | -267.35% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.00 | $-0.00 | $-0.01 | $-0.01 | $-0.01 |
| Wtd Avg Shares | 736.62M | 719.84M | 316.44M | 102.56M | 61.86M |
| EBITDA | ($1.11M) | ($1.14M) | ($0.92M) | ($0.58M) | ($0.46M) |
| EBITDA Margin %(computed) | -38.95% | -28.29% | -18.83% | -15.66% | -189.15% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Oncologix Tech, Inc. data
About Oncologix Tech, Inc. (OCLG) Income Statement
Oncologix Tech, Inc. (OCLG) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2017, OCLG reported revenue of $0.00B, gross profit of $0.00B (gross margin 20.05%), and net income of ($0.00B) — a net profit margin of -83.19%.
Frequently asked questions
OCLG · 4 questionsOncologix Tech, Inc. (OCLG) reported revenue of $0.00B for 2017, down 29.0% year-over-year.
OCLG revenueOCLG salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09